Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of HQ® Matrix Medical Wound Dressing for Healing of Donor Site Wounds

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Patients, aged from 18 - 60, male or female, with wet wounds or burns, ulcerative skin and soft tissue wound surfaces;~2. The wound surface area ranged from 20cm\^2 to 600cm\^2;~3. The patients had a clear mind and there was no misunderstanding;~4. The patients voluntarily signed the subjects' informed consent form and received timely follow-ups.~Exclusion Criteria:~1. Patients with active bleeding in wound surfaces;~2. Vasogenic diseases: patients with no blood supply or phlebothrombosis in local wound tissues;~3. Those allergic to silk materials;~4. Those with serious infection;~5. Those with coagulation disorders;~6. Those with tumors or diabetes;~7. Patients who, according to other doctors' opinion, are unsuitable to use this material for wound treatment.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- HQ® Matrix Medical Wound Dressing (Type: EXPERIMENTAL): After harvesting the graft, the donor site wounds were treated with the dressing material. Dressing changes if needed. An operative removal of the HQ® Matrix Medical Wound Dressing is not required as it becomes spontaneously detached from the regenerated skin areas.
- Sidaiyi® wound dressing (Type: ACTIVE_COMPARATOR): After harvesting the graft, the donor site wounds were treated with the dressing material. Dressing changes if needed.

Based on this trial design, predict the completion outcome and termination type (if applicable).